- Impact of Pathological Characteristics on Local Relapse After Breast-Conserving Therapy: A Subgroup Analysis of the EORTC Boost Versus No Boost Trial
[作者：Jones, HA; Antonini, N; Hart, AAM; Peterse, JL; Horiot, JC; Collin, F; Poortmans, PM; Oei, SB; Collette, L; Struikmans, H; van den Bogaert, WF; Fourquet, A; Jager, JJ; Schinagl, DAX; Warlam-Rodenhuis, CC; Bartelink, H,期刊：Journal of clinical oncology, 页码：4939-4947 , 文章类型： Article，,卷期：2009年27-30]
- Purpose To investigate the long-term impact of pathologic characteristics and an extra boost dose of 16 Gy on local relapse, for stage I and II invasive breast cancer patients treated with breast conserving therapy (BCT)...
- Occult Nipple Involvement in Breast Cancer: Clinicopathologic Findings in 316 Consecutive Mastectomy Specimens
[作者：Brachtel, EF; Rusby, JE; Michaelson, JS; Chen, LL; Muzikansky, A; Smith, BL; Koerner, FC,期刊：Journal of clinical oncology, 页码：4948-4954 , 文章类型： Article，,卷期：2009年27-30]
- Purpose Although breast-conserving surgery is a standard approach for patients with breast cancer, mastectomy often becomes necessary. Surgical options now include nipple-sparing mastectomy but its oncological safety is ...
- Sonographic and Electrodiagnostic Evaluations in Patients With Aromatase Inhibitor-Related Arthralgia
[作者：Dizdar, O; Ozcakar, L; Malas, FU; Harputluoglu, H; Bulut, N; Aksoy, S; Ozisik, Y; Altundag, K,期刊：Journal of clinical oncology, 页码：4955-4960 , 文章类型： Article，,卷期：2009年27-30]
- Purpose To investigate the prevalence of arthralgia in breast cancer patients taking aromatase inhibitors (AIs) and perform a detailed rheumatologic assessment including autoimmune serology, musculoskeletal sonography, a...
- Independent Review of E2100: A Phase III Trial of Bevacizumab Plus Paclitaxel Versus Paclitaxel in Women With Metastatic Breast Cancer
[作者：Gray, R; Bhattacharya, S; Bowden, C; Miller, K; Comis, RL,期刊：Journal of clinical oncology, 页码：4966-4972 , 文章类型： Article，,卷期：2009年27-30]
- Purpose E2100, an open-label, randomized, phase III trial conducted by the Eastern Cooperative Oncology Group (ECOG), demonstrated a significant improvement in progression-free survival (PFS) and overall response rate (O...
- Myeloperoxidase Genotypes and Enhanced Efficacy of Chemotherapy for Early-Stage Breast Cancer in SWOG-8897
[作者：Ambrosone, CB; Barlow, WE; Reynolds, W; Livingston, RB; Yeh, IT; Choi, JY; Davis, W; Rae, JM; Tang, L; Hutchins, LR; Ravdin, PM; Martino, S; Osborne, CK; Lyss, AP; Hayes, DF; Albain, KS,期刊：Journal of clinical oncology, 页码：4973-4979 , 文章类型： Article，,卷期：2009年27-30]
- Purpose Myeloperoxidase (MPO) generates reactive oxygen species and also activates xenobiotics. In a rigorous clinical trial (Southwest Oncology Group SWOG-8897), we examined relationships between genotypes and disease-f...
- Prospective Study of Determinants and Outcomes of Deferred Treatment or Watchful Waiting Among Men With Prostate Cancer in a Nationwide Cohort
[作者：Shappley, WV; Kenfield, SA; Kasperzyk, JL; Qiu, WL; Stampfer, MJ; Sanda, MG; Chan, JM,期刊：Journal of clinical oncology, 页码：4980-4985 , 文章类型： Article，,卷期：2009年27-30]
- Purpose To examine consequences of deferred treatment (DT) as initial management of prostate cancer (PCa) in a contemporary, prospective cohort of American men diagnosed with PCa. Participants and Methods We evaluated de...
- Phase II, Randomized, Placebo-Controlled Trial of Neoadjuvant Celecoxib in Men With Clinically Localized Prostate Cancer: Evaluation of Drug-Specific Biomarkers
[作者：Antonarakis, ES; Heath, EI; Walczak, JR; Nelson, WG; Fedor, H; De Marzo, AM; Zahurak, ML; Piantadosi, S; Dannenberg, AJ; Gurganus, RT; Baker, SD; Parnes, HL; DeWeese, TL; Partin, AW; Carducci, MA,期刊：Journal of clinical oncology, 页码：4986-4993 , 文章类型： Article，,卷期：2009年27-30]
- Purpose Cyclooxygenase-2 (COX-2) is a potential pharmacologic target for the prevention of various malignancies, including prostate cancer. We conducted a randomized, double-blind trial to examine the effect of celecoxib...
- Rotterdam Criteria for Sentinel Node (SN) Tumor Burden and the Accuracy of Ultrasound (US) -Guided Fine-Needle Aspiration Cytology (FNAC): Can US-Guided FNAC Replace SN Staging in Patients With Melanoma?
[作者：Voit, CA; van Akkooi, ACJ; Schafer-Hesterberg, G; Schoengen, A; Schmitz, PIM; Sterry, W; Eggermont, AMM,期刊：Journal of clinical oncology, 页码：4994-5000 , 文章类型： Article，,卷期：2009年27-30]
- Purpose Sentinel node (SN) status is the most important prognostic factor for overall survival (OS) for patients with stage I/II melanoma, and the role of the SN procedure as a staging procedure has long been established...
- Short-Term Thalidomide Incorporated Into Double Autologous Stem-Cell Transplantation Improves Outcomes in Comparison With Double Autotransplantation for Multiple Myeloma
[作者：Cavo, M; Di Raimondo, F; Zamagni, E; Patriarca, F; Tacchetti, P; Casulli, AF; Volpe, S; Perrone, G; Ledda, A; Ceccolini, M; Califano, C; Bigazzi, C; Offidani, M; Stefani, P; Ballerini, F; Fiacchini, M; de Vivo, A; Brioli, A; Tosi, P; Baccarani, M,期刊：Journal of clinical oncology, 页码：5001-5007 , 文章类型： Article，,卷期：2009年27-30]
- Purpose To assess potential benefits with thalidomide incorporated into double autologous stem-cell transplantation (ASCT) for younger patients with newly diagnosed multiple myeloma (MM). Patients and Methods One hundred...
- Pomalidomide (CC4047) Plus Low-Dose Dexamethasone As Therapy for Relapsed Multiple Myeloma
[作者：Lacy, MQ; Hayman, SR; Gertz, MA; Dispenzieri, A; Buadi, F; Kumar, S; Greipp, PR; Lust, JA; Russell, SJ; Dingli, D; Kyle, RA; Fonseca, R; Bergsagel, PL; Roy, V; Mikhael, JR; Stewart, AK; Laumann, K; Allred, JB; Mandrekar, SJ; Rajkumar, SV,期刊：Journal of clinical oncology, 页码：5008-5014 , 文章类型： Proceedings Paper，,卷期：2009年27-30]
- Purpose Thalidomide and lenalidomide are immunomodulatory drugs (IMiDs) that produce high remission rates in the treatment of multiple myeloma. Pomalidomide is a new IMiD with high in vitro potency. We report, to our kno...
|